Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hong

Showing results (721-730 of 752) with videos related to

Pageof 76
Sort By:
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Cell Reports|November 21, 2019
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate CancerJustin H Hwang, Ji-Heui Seo, Michael L Beshiri, et al.
Nature Reviews. Urology|October 17, 2023
Hallmark discoveries in the biology of Wilms tumourDaniela Perotti, Richard D Williams, Jenny Wegert, et al.
Cell Reports|July 14, 2021
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16qJasper E Neggers, Brenton R Paolella, Adhana Asfaw, et al.
Cell Reports|December 16, 2020
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16qJasper E Neggers, Brenton R Paolella, Adhana Asfaw, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2005
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P'2 moiety with improved potencyA Arasappan, F G Njoroge, T-Y Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
Research Square|March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q StudyAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|December 18, 2023
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-QAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Pageof 76

Showing results (721-730 of 752) with videos related to

Sort By:
Pageof 76
Cancer Research|February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid TumorsThomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Cell Reports|November 21, 2019
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate CancerJustin H Hwang, Ji-Heui Seo, Michael L Beshiri, et al.
Nature Reviews. Urology|October 17, 2023
Hallmark discoveries in the biology of Wilms tumourDaniela Perotti, Richard D Williams, Jenny Wegert, et al.
Cell Reports|July 14, 2021
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16qJasper E Neggers, Brenton R Paolella, Adhana Asfaw, et al.
Cell Reports|December 16, 2020
Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16qJasper E Neggers, Brenton R Paolella, Adhana Asfaw, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2005
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P'2 moiety with improved potencyA Arasappan, F G Njoroge, T-Y Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trialH C Toh, M-H Yang, H-M Wang, et al.
Research Square|March 30, 2023
The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q StudyAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|December 18, 2023
Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-QAndrew J Murphy, Changde Cheng, Justin Williams, et al.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Pageof 76